Stock Sanofi SAN.PA

Investlytic score: 3/5 criteria met. Data as of 17/09/2026.

• ❌ Price trend failed
• ✅ Growth passed
• ✅ Debt passed
• ✅ P/E passed
• ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2018 → 2019: 18.45%

Price change 2019 → 2020: -12.18%

Price change 2020 → 2021: 12.55%

Price change 2021 → 2022: 1.42%

Price change 2022 → 2023: -0.09%

Price change 2023 → 2024: 4.43%

Price change 2024 → 2025: -11.76%

Price change 2025 → 2026: -8.85%

Price change 2026 (year to date): -8.41%

Financial growth

Revenue CAGR (8 years): 3.93%

Earnings CAGR (8 years): 8.88%

Growth status: positive trend (>1%/yr) in revenue and earnings.

Debt

Debt-to-equity ratio: 0.28

Debt/equity < 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 8.40

P/E < 25.0 (maximum threshold).

Correction (6 months)

Current correction: 9.01% from the high over 6 months.

Insufficient correction (< 10.0%).